Life science companies are often challenged to meet forecasts and maximize the growth of their therapies at any cost – with gross-to-net (GTN) often taking the biggest hit. In today’s market conditions, manufacturers can no longer afford to overlook GTN when building and scaling a patient access strategy. Read this white paper to discover the ultimate playbook for aligning the internal teams that have a stake in your brand’s success - including marketing, sales, market access, and patient services - to balance maximum patient access with a sustainable GTN
Effective patient support services are essential in the age of utilization management - read this white paper to learn how to optimize your program.
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.